Contact Us
  Search
The Business Research Company Logo
Sequencer As A Service Market Report 2026
Published :April 2026
Pages :250
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Sequencer As A Service Market Report 2026

Global Outlook – By Component (Software, Hardware, Services), By Service Type (Sample Preparation Services, Library Preparation Services, Sequencing Execution Services, Bioinformatics Analysis Services, Data Storage And Management Services, Integrated End-to-End Sequencing Services), By Deployment Mode (Cloud-Based, On-Premises), By Application (Clinical Diagnostics, Oncology Research, Rare Disease Research, Infectious Disease Surveillance, Drug Discovery And Development, Agrigenomics, Forensic Genomics, Reproductive Health Testing, Personalized Medicine Research), By End-User (Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Academic Institutions, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Sequencer As A Service Market Overview

• Sequencer As A Service market size has reached to $2.31 billion in 2025 • Expected to grow to $5.73 billion in 2030 at a compound annual growth rate (CAGR) of 20% • Growth Driver: Increasing Prevalence Of Genetic Disorders Fueling The Growth Of The Market Due To Rising Demand For Early Detection And Accurate Genomic Diagnosis • Market Trend: Integration Of Artificial Intelligence-Driven Bioinformatics Platforms And Certified Service Provider Accreditation Initiatives In Sequencer-As-A-Service (Saas) Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
Research Expert

Book your 30 minutes free consultation with our research experts

What Is Covered Under Sequencer As A Service Market?

Sequencer as a service is a business model in which genomic sequencing capabilities are provided to customers on a contractual or pay-per-use basis rather than through the purchase of sequencing equipment. It enables organizations to access advanced DNA and RNA sequencing technologies, laboratory infrastructure, and bioinformatics analysis without investing in in-house platforms. This model reduces capital expenditure, improves scalability, and accelerates research, diagnostics, and innovation by delivering end-to-end sequencing solutions through specialized providers. The main components of sequencer as a service include software, hardware, and services. Software refers to platforms that manage sequencing workflows, data analysis, and reporting for end-to-end genomics solutions. The service types include sample preparation services, library preparation services, sequencing execution services, bioinformatics analysis services, data storage and management services, and integrated end-to-end sequencing services and are deployed through cloud-based and on-premises modes. The various applications involved are clinical diagnostics, oncology research, rare disease research, infectious disease surveillance, drug discovery and development, agrigenomics, forensic genomics, reproductive health testing, and personalized medicine research, and are used by several end users such as hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, academic institutions, and other end users.
Sequencer As A Service market report bar graph

What Is The Sequencer As A Service Market Size and Share 2026?

The sequencer as a service market size has grown rapidly in recent years. It will grow from $2.31 billion in 2025 to $2.76 billion in 2026 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to rising demand for genomic research, limited access to in-house sequencing platforms, high cost of sequencing instruments, growth in personalized medicine initiatives, increasing collaborations between research institutes and sequencing providers.

What Is The Sequencer As A Service Market Growth Forecast?

The sequencer as a service market size is expected to see exponential growth in the next few years. It will grow to $5.73 billion in 2030 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to adoption of cloud-based sequencing solutions, demand for high-throughput sequencing services, integration of ai-driven bioinformatics analysis, expansion of clinical genomics applications, increasing outsourcing of sequencing services. Major trends in the forecast period include cloud-based sequencing services, automated sample preparation, integrated bioinformatics solutions, pay-per-use sequencing models, scalable genomic data management.

Global Sequencer As A Service Market Segmentation

1) By Component: Software, Hardware, Services 2) By Service Type: Sample Preparation Services, Library Preparation Services, Sequencing Execution Services, Bioinformatics Analysis Services, Data Storage And Management Services, Integrated End-to-End Sequencing Services 3) By Deployment Mode: Cloud-Based, On-Premises 4) By Application: Clinical Diagnostics, Oncology Research, Rare Disease Research, Infectious Disease Surveillance, Drug Discovery And Development, Agrigenomics, Forensic Genomics, Reproductive Health Testing, Personalized Medicine Research 5) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Academic Institutions, Other End Users Subsegments: 1) By Software: Bioinformatics Analysis Platforms, Sequence Data Management Systems, Variant Interpretation Tools, Workflow Automation Software, Cloud-Based Data Processing Platforms 2) By Hardware: High Throughput Sequencing Instruments, Sample Preparation Systems, Laboratory Automation Equipment, Data Storage Servers, High Performance Computing Infrastructure 3) By Services: Sample Processing Services, Library Preparation Services, Sequencing Execution Services, Bioinformatics Interpretation Services, Data Storage And Management Services, Consulting And Technical Support Services

What Is The Driver Of The Sequencer As A Service Market?

The increasing prevalence of genetic disorders is expected to propel the growth of the sequencer as a service market going forward. Genetic disorders refer to medical conditions caused by abnormalities in an individual's deoxyribonucleic acid, inherited from one or both parents or arising from new mutations. The increasing genetic disorders are increasing due to rising parental age, as older parents have a higher risk of passing on genetic mutations to their children. Sequencer as a service helps address genetic disorders by providing scalable and on-demand access to advanced DNA and RNA sequencing technologies, enabling early detection and accurate diagnosis. It reduces infrastructure and operational burdens for laboratories and healthcare providers by offering cloud-based data analysis and expert support, improving precision medicine outcomes and research efficiency. For instance, in May 2024, according to the National Health Service, a UK-based government department, there are 17,000 people living with sickle cell disease, an inherited genetic blood disorder, with around 250 new cases diagnosed each year. Therefore, the increasing prevalence of genetic disorders is driving the growth of the sequencer as a service industry.

Key Players In The Global Sequencer As A Service Market

Major companies operating in the sequencer as a service market are Admera Health, ArrayGen Technologies, BGI Genomics Co. Ltd., CD Genomics Inc., Element Biosciences, Eurofins Scientific SE, Gene by Gene, GENEWIZ Germany GmbH, Illumina Inc., Karkinos Healthcare, Lucigen, Macrogen Inc., MedGenome Labs Ltd., Novogene Co. Ltd., Quest Diagnostics, SeqMatic LLC, SeqWell, Strand Life Sciences Pvt. Ltd., Veritas Genetics, Yaazh Xenomics.

What Are Latest Mergers And Acquisitions In The Sequencer As A Service Market?

In February 2026, Swiss Rockets AG, a Switzerland-based life sciences venture builder, acquired Complete Genomics Inc. for an undisclosed amount. Through this acquisition, Swiss Rockets AG aims to strengthen its biotechnology development portfolio, accelerate precision medicine innovation, and expand global sequencing technology capabilities. Complete Genomics Inc. is a US-based genomics company that is involved in the sequencer-as-a-service model by offering outsourced sequencing services alongside selling its proprietary DNBSEQ™ instruments.

Regional Insights

North America was the largest region in the sequencer as a service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Sequencer As A Service Market?

The sequencer as a service market includes revenues earned by entities through on-demand genomic sequencing solutions, laboratory processing, transcriptome sequencing services, and cloud-based genomic data management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Sequencer As A Service Market Report 2026?

The sequencer as a service market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sequencer as a service industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Sequencer As A Service Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$2.76 billion
Revenue Forecast In 2035$5.73 billion
Growth RateCAGR of 19.8% from 2026 to 2035
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030 - 2035
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2035
Segments CoveredComponent, Service Type, Deployment Mode, Application, End-User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Key Companies ProfiledAdmera Health, ArrayGen Technologies, BGI Genomics Co. Ltd., CD Genomics Inc., Element Biosciences, Eurofins Scientific SE, Gene by Gene, GENEWIZ Germany GmbH, Illumina Inc., Karkinos Healthcare, Lucigen, Macrogen Inc., MedGenome Labs Ltd., Novogene Co. Ltd., Quest Diagnostics, SeqMatic LLC, SeqWell, Strand Life Sciences Pvt. Ltd., Veritas Genetics, Yaazh Xenomics.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us